IBDEI11M ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16953,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16953,1,3,0)
;;=3^Peliosis Hepatis
;;^UTILITY(U,$J,358.3,16953,1,4,0)
;;=4^K76.4
;;^UTILITY(U,$J,358.3,16953,2)
;;=^91041
;;^UTILITY(U,$J,358.3,16954,0)
;;=K71.50^^61^778^27
;;^UTILITY(U,$J,358.3,16954,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16954,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
;;^UTILITY(U,$J,358.3,16954,1,4,0)
;;=4^K71.50
;;^UTILITY(U,$J,358.3,16954,2)
;;=^5008799
;;^UTILITY(U,$J,358.3,16955,0)
;;=K71.51^^61^778^28
;;^UTILITY(U,$J,358.3,16955,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16955,1,3,0)
;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
;;^UTILITY(U,$J,358.3,16955,1,4,0)
;;=4^K71.51
;;^UTILITY(U,$J,358.3,16955,2)
;;=^5008800
;;^UTILITY(U,$J,358.3,16956,0)
;;=K71.7^^61^778^31
;;^UTILITY(U,$J,358.3,16956,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16956,1,3,0)
;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
;;^UTILITY(U,$J,358.3,16956,1,4,0)
;;=4^K71.7
;;^UTILITY(U,$J,358.3,16956,2)
;;=^5008802
;;^UTILITY(U,$J,358.3,16957,0)
;;=K71.8^^61^778^35
;;^UTILITY(U,$J,358.3,16957,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16957,1,3,0)
;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
;;^UTILITY(U,$J,358.3,16957,1,4,0)
;;=4^K71.8
;;^UTILITY(U,$J,358.3,16957,2)
;;=^5008803
;;^UTILITY(U,$J,358.3,16958,0)
;;=K71.9^^61^778^36
;;^UTILITY(U,$J,358.3,16958,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16958,1,3,0)
;;=3^Toxic Liver Disease,Unspec
;;^UTILITY(U,$J,358.3,16958,1,4,0)
;;=4^K71.9
;;^UTILITY(U,$J,358.3,16958,2)
;;=^5008804
;;^UTILITY(U,$J,358.3,16959,0)
;;=K75.2^^61^778^22
;;^UTILITY(U,$J,358.3,16959,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16959,1,3,0)
;;=3^Nonspecific Reactive Hepatitis
;;^UTILITY(U,$J,358.3,16959,1,4,0)
;;=4^K75.2
;;^UTILITY(U,$J,358.3,16959,2)
;;=^5008826
;;^UTILITY(U,$J,358.3,16960,0)
;;=K75.3^^61^778^13
;;^UTILITY(U,$J,358.3,16960,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16960,1,3,0)
;;=3^Granulomatous Hepatitis NEC
;;^UTILITY(U,$J,358.3,16960,1,4,0)
;;=4^K75.3
;;^UTILITY(U,$J,358.3,16960,2)
;;=^5008827
;;^UTILITY(U,$J,358.3,16961,0)
;;=K76.6^^61^778^24
;;^UTILITY(U,$J,358.3,16961,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16961,1,3,0)
;;=3^Portal Hypertension
;;^UTILITY(U,$J,358.3,16961,1,4,0)
;;=4^K76.6
;;^UTILITY(U,$J,358.3,16961,2)
;;=^5008834
;;^UTILITY(U,$J,358.3,16962,0)
;;=K74.00^^61^778^16
;;^UTILITY(U,$J,358.3,16962,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16962,1,3,0)
;;=3^Hepatic Fibrosis,Unspec
;;^UTILITY(U,$J,358.3,16962,1,4,0)
;;=4^K74.00
;;^UTILITY(U,$J,358.3,16962,2)
;;=^5159218
;;^UTILITY(U,$J,358.3,16963,0)
;;=K74.01^^61^778^15
;;^UTILITY(U,$J,358.3,16963,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16963,1,3,0)
;;=3^Hepatic Fibrosis,Early Fibrosis
;;^UTILITY(U,$J,358.3,16963,1,4,0)
;;=4^K74.01
;;^UTILITY(U,$J,358.3,16963,2)
;;=^5159219
;;^UTILITY(U,$J,358.3,16964,0)
;;=K74.02^^61^778^14
;;^UTILITY(U,$J,358.3,16964,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16964,1,3,0)
;;=3^Hepatic Fibrosis,Advanced Fibrosis
;;^UTILITY(U,$J,358.3,16964,1,4,0)
;;=4^K74.02
;;^UTILITY(U,$J,358.3,16964,2)
;;=^5159220
;;^UTILITY(U,$J,358.3,16965,0)
;;=F20.3^^61^779^31
;;^UTILITY(U,$J,358.3,16965,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI11M 3750 printed Sep 23, 2025@19:35:59 Page 2
IBDEI11M ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16953,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,16953,1,3,0)
+4 ;;=3^Peliosis Hepatis
+5 ;;^UTILITY(U,$J,358.3,16953,1,4,0)
+6 ;;=4^K76.4
+7 ;;^UTILITY(U,$J,358.3,16953,2)
+8 ;;=^91041
+9 ;;^UTILITY(U,$J,358.3,16954,0)
+10 ;;=K71.50^^61^778^27
+11 ;;^UTILITY(U,$J,358.3,16954,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,16954,1,3,0)
+14 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/o Ascites
+15 ;;^UTILITY(U,$J,358.3,16954,1,4,0)
+16 ;;=4^K71.50
+17 ;;^UTILITY(U,$J,358.3,16954,2)
+18 ;;=^5008799
+19 ;;^UTILITY(U,$J,358.3,16955,0)
+20 ;;=K71.51^^61^778^28
+21 ;;^UTILITY(U,$J,358.3,16955,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,16955,1,3,0)
+24 ;;=3^Toxic Liver Disease w/ Chronic Active Hepatitis w/ Ascites
+25 ;;^UTILITY(U,$J,358.3,16955,1,4,0)
+26 ;;=4^K71.51
+27 ;;^UTILITY(U,$J,358.3,16955,2)
+28 ;;=^5008800
+29 ;;^UTILITY(U,$J,358.3,16956,0)
+30 ;;=K71.7^^61^778^31
+31 ;;^UTILITY(U,$J,358.3,16956,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,16956,1,3,0)
+34 ;;=3^Toxic Liver Disease w/ Fibrosis & Cirrhosis of Liver
+35 ;;^UTILITY(U,$J,358.3,16956,1,4,0)
+36 ;;=4^K71.7
+37 ;;^UTILITY(U,$J,358.3,16956,2)
+38 ;;=^5008802
+39 ;;^UTILITY(U,$J,358.3,16957,0)
+40 ;;=K71.8^^61^778^35
+41 ;;^UTILITY(U,$J,358.3,16957,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,16957,1,3,0)
+44 ;;=3^Toxic Liver Disease w/ Oth Disorders of Liver
+45 ;;^UTILITY(U,$J,358.3,16957,1,4,0)
+46 ;;=4^K71.8
+47 ;;^UTILITY(U,$J,358.3,16957,2)
+48 ;;=^5008803
+49 ;;^UTILITY(U,$J,358.3,16958,0)
+50 ;;=K71.9^^61^778^36
+51 ;;^UTILITY(U,$J,358.3,16958,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,16958,1,3,0)
+54 ;;=3^Toxic Liver Disease,Unspec
+55 ;;^UTILITY(U,$J,358.3,16958,1,4,0)
+56 ;;=4^K71.9
+57 ;;^UTILITY(U,$J,358.3,16958,2)
+58 ;;=^5008804
+59 ;;^UTILITY(U,$J,358.3,16959,0)
+60 ;;=K75.2^^61^778^22
+61 ;;^UTILITY(U,$J,358.3,16959,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,16959,1,3,0)
+64 ;;=3^Nonspecific Reactive Hepatitis
+65 ;;^UTILITY(U,$J,358.3,16959,1,4,0)
+66 ;;=4^K75.2
+67 ;;^UTILITY(U,$J,358.3,16959,2)
+68 ;;=^5008826
+69 ;;^UTILITY(U,$J,358.3,16960,0)
+70 ;;=K75.3^^61^778^13
+71 ;;^UTILITY(U,$J,358.3,16960,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,16960,1,3,0)
+74 ;;=3^Granulomatous Hepatitis NEC
+75 ;;^UTILITY(U,$J,358.3,16960,1,4,0)
+76 ;;=4^K75.3
+77 ;;^UTILITY(U,$J,358.3,16960,2)
+78 ;;=^5008827
+79 ;;^UTILITY(U,$J,358.3,16961,0)
+80 ;;=K76.6^^61^778^24
+81 ;;^UTILITY(U,$J,358.3,16961,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,16961,1,3,0)
+84 ;;=3^Portal Hypertension
+85 ;;^UTILITY(U,$J,358.3,16961,1,4,0)
+86 ;;=4^K76.6
+87 ;;^UTILITY(U,$J,358.3,16961,2)
+88 ;;=^5008834
+89 ;;^UTILITY(U,$J,358.3,16962,0)
+90 ;;=K74.00^^61^778^16
+91 ;;^UTILITY(U,$J,358.3,16962,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,16962,1,3,0)
+94 ;;=3^Hepatic Fibrosis,Unspec
+95 ;;^UTILITY(U,$J,358.3,16962,1,4,0)
+96 ;;=4^K74.00
+97 ;;^UTILITY(U,$J,358.3,16962,2)
+98 ;;=^5159218
+99 ;;^UTILITY(U,$J,358.3,16963,0)
+100 ;;=K74.01^^61^778^15
+101 ;;^UTILITY(U,$J,358.3,16963,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,16963,1,3,0)
+104 ;;=3^Hepatic Fibrosis,Early Fibrosis
+105 ;;^UTILITY(U,$J,358.3,16963,1,4,0)
+106 ;;=4^K74.01
+107 ;;^UTILITY(U,$J,358.3,16963,2)
+108 ;;=^5159219
+109 ;;^UTILITY(U,$J,358.3,16964,0)
+110 ;;=K74.02^^61^778^14
+111 ;;^UTILITY(U,$J,358.3,16964,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,16964,1,3,0)
+114 ;;=3^Hepatic Fibrosis,Advanced Fibrosis
+115 ;;^UTILITY(U,$J,358.3,16964,1,4,0)
+116 ;;=4^K74.02
+117 ;;^UTILITY(U,$J,358.3,16964,2)
+118 ;;=^5159220
+119 ;;^UTILITY(U,$J,358.3,16965,0)
+120 ;;=F20.3^^61^779^31
+121 ;;^UTILITY(U,$J,358.3,16965,1,0)
+122 ;;=^358.31IA^4^2
